Continuous direct compression can provide a simplified alternative pathway for selected spray-dried dispersion formulations ...
Centrix and University of Sussex launch a data analytics partnership to reduce development risk, rework and delays in early-stage pharma programs. A collaboration between Centrix Pharma Solutions, a ...
As 3D printers become more accessible and easier to use, researchers are finding new ways to incorporate this technology into their work. 1 3D bioprinters utilizing natural, synthetic, and hybrid ...
FDA priority review of Jemperli for biomarker-defined rectal cancer signals capacity, supply chain, and global filing shifts ...
McKesson plans to absorb Precision Medicine Group into Oncology & Multispecialty, adding CRO, lab, biomarker, market access, and commercialization capabilities to its existing healthcare services ...
David S. Thompson, CSAP, is Chief Alliance Officer at Eli Lilly and Company.
FDA imposed a clinical hold on RGX-121 after spine MRI surveillance detected asymptomatic spinal nodules/cystic masses in five participants dosed intracisternally or intraventricularly 3–6 years prior ...
Schmitt and Schniepp stress that merely citing a standard (e.g., "we followed GAMP") doesn't guarantee compliance. According ...
On August 19,2026, the FDA accepted Teva Pharmaceuticals' New Drug Application (NDA) for ecopipam, an investigational ...
Chris Williams serves as executive director, Analytical Development ILM at Alcami, bringing more than a decade of experience ...
Accelerated approval relies on cornstarch-reduction as a surrogate endpoint, with crossover follow-up planned at 96 and 144 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results